Improving treatment for addiction means first recognizing that addiction is a chronic disease and also understanding that relapse is part of the disease process, explained Frank James, MD, JD, of American Society of Addiction Medicine.
Improving treatment for addiction means first recognizing that addiction is a chronic disease and also understanding that relapse is part of the disease process, explained Frank James, MD, JD, of American Society of Addiction Medicine.
Transcript (slightly modified)
How can health systems and practices improve treatment for patients with addiction?
We have to first recognize that it is a chronic disease. It’s not a moral disease, it’s not a disease that measures someone’s efforts or their desire to get better—it really is a medical disease. We do have evidence-based care and evidence-based treatments that work. So, we have to make sure that all of our models are based on a chronic disease model.
People often say that if you relapse then the treatment didn’t work; we realize that relapse is a part of the disease process. But the important thing is: how do we treat people who do relapse that we don’t pass judgement on them, we make sure that they’re welcome to come back to treatment, that they’re still engaged? And how do we change the treatment afterwards to make sure that what didn’t work before that we can improve on that?
So really, we have to look at this as a chronic disease with evidence-based treatments for a specific population that has specific needs, and then we need to engage them.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Specialty Pharmacists at the Forefront: Elevating Care for Rare Diseases
May 1st 2024In the US, a disease is considered rare when it affects fewer than 200,000 persons, or 1 in every 1500 individuals, with an estimated total of 25 to 30 million Americans overall living with a rare disease at any given time.
Read More
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More